摘要
目的 观察新活素对老年失代偿性心衰合并慢性肾功能不全患者的治疗效果。方法 选择我院2019年10月到2021年4月中所收治的100例老年失代偿性心衰的患者，并从中筛选出失代偿性心衰合并肾功能不全的患者96例为本次研究的主要研究对象，利用平均分配到方式将患者分为观察组（48例）和对组（48例），为对照组患者进行常规等等治疗方式，而观察组的患者在对照组的基础上极爱入了新活素，比较两组患者在心率、左心室射血分数（LVEF）、24小时的尿量上的情况。结果 观察组患者的治疗有效率为95.8%，好于对照组的68.8%，两组之间比较具有统计学意义（P＜0.05）；观察组患者在心率、LVEF和24小时的尿量上都好于对照组（P＜0.05）。结论 为老年失代偿性心衰合并慢性肾功能不全的患者使用新活素进行治疗 ，有着较好的治疗效果。
关键词： 新活素；老年失代偿性；心衰；慢性肾功能不全；疗效
Abstract
Objective To observe the therapeutic effect of Xinhuosu on elderly patients with decompensated heart failure and chronic renal insufficiency. Methods 400 cases of elderly patients with decompensated heart failure in our hospital from April 2019 to April 2021 were selected, and 96 cases of patients with decompensated heart failure and renal insufficiency were selected as the main research objects of this study. The patients were divided into observation group (48 cases) and control group (48 cases) by average allocation method, and the control group was given conventional treatment, On the basis of the control group, the patients in the observation group were very fond of Xinhuosu. The heart rate, left ventricular ejection fraction (LVEF) and 24-hour urine volume of the two groups were compared. Results the effective rate of the observation group was 95.8%, which was better than 68.8% of the control group (P < 0.05); The heart rate, LVEF and 24-hour urine volume of the observation group were better than those of the control group (P < 0.05). Conclusion for the elderly patients with decompensated heart failure combined with chronic renal insufficiency, the use of new activin has a good therapeutic effect.
Key words： Xinhuosu; The elderly are decompensated; Heart failure; Chronic renal insufficiency; curative effect
参考文献 References
[1] 田永波,张会军,郭宏.新活素对老年失代偿期心衰患者临床症状及BNP水平的影响[J].贵州医药,2021,45(05):729-730.
[2] 张立,王志伟.新活素对老年失代偿期心衰患者BNP的影响及临床疗效观察[J].中国现代药物应用,2018,12(06):124-125.
[3] 常连庆,赵香芳,刘乃琴,吕春雷,王文博,王仙花,孔原,韩升祥,王喻.新活素对老年失代偿性心力衰竭患者心功能的影响[J].中国循证心血管医学杂志,2018,10(03):345-347.
[4] 张安吉,王婷,张阿宁.新活素对老年急性失代偿期心力衰竭患者心功能及尿量的影响[J].中国老年学杂志,2017,37(18):4533-4534.
[5] 常连庆, 赵香芳, 刘乃琴,等. 新活素对老年失代偿性心力衰竭患者心功能的影响[J]. 中国循证心血管医学杂志, 2018, 10(3):3.
[6] 孙彦琴, 贾永平, 吕吉元. 不同剂量新活素治疗急性失代偿性心力衰竭合并肾功能不全的疗效观察[J]. 中西医结合心血管病电子杂志, 2020, 8(19):2.
[7] 古丽尼沙•吾布力卡斯木, 卖卖提•热夏提. 新活素治疗失代偿性心衰合并肺动脉高压的临床效果分析[J]. 中国保健营养, 2018, 028(022):238.
[8] 冯振勤, 周伟伟, 赵波,等. 新活素治疗失代偿性心衰合并肺动脉高压的临床疗效观察[J]. 贵州医药, 2017, 41(2):2.
[9] 石俊松. 新活素用于急性失代偿性心衰患者的疗效评价[J]. 智慧健康, 2021, 7(19):3.
[10] 王菲. 新活素治疗失代偿性心衰合并肺动脉高压的效果分析[J]. 中国冶金工业医学杂志, 2018, 35(4):2.
[11] 杨盛. 新活素用于急性失代偿性心衰患者的疗效评价[J]. 医药与保健, 2018.
[12] 田永波, 张会军, 郭宏. 新活素对老年失代偿期心衰患者临床症状及BNP水平的影响[J]. 贵州医药, 2021.
[13] 邱晓燕, 秦艳, 韩忠源,等. 新活素治疗急性失代偿性心力衰竭效果观察[J]. 交通医学, 2018, 32(5):4.
[14] 李淑瑾. 新活素治疗老年失代偿期心衰疗效及护理观察[J]. 中国城乡企业卫生, 2022, 37(5):3.